4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-013244
Director sold 44,000 shares at an average $57.99 ($2,551,440)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2018-05-15 | Sale | −43,000 | $57.97 | $2,492,710 | 641,014 | I |
| Bolzon Bradley J PhD Director | 2018-05-15 | Sale | −1,000 | $58.73 | $58,730 | 640,014 | I |
| Open-market sales · 44,000 sh · avg $57.99 · $2,551,440 | |||||||
Loading xslF345X03/doc4.xml…